A 28-year-old woman with a 3-year history of systemic lupus erythematosus (SLE) presents to the nephrology clinic with a 2-week history of worsening bilateral lower extremity edema, frothy urine, and new-onset headaches. Her home medications include hydroxychloroquine and naproxen. Her blood pressure is 162/98 mmHg. Physical examination reveals 2+ pitting edema up to the mid-calves and a faint erythematous malar rash. Recent laboratory studies show newly depressed C3 and C4 complement levels and a markedly elevated anti-dsDNA titer. Assuming the patient's clinical condition progresses as expected for a severe renal flare, arrange the following diagnostic and therapeutic steps in the correct chronological sequence for standard management.
- 1Obtain a urinalysis and spot urine protein-to-creatinine ratio.
- 2Perform an ultrasound-guided percutaneous renal biopsy to establish histologic classification.
- 3Initiate induction therapy with high-dose corticosteroids and mycophenolate mofetil.
- 4Transition to a less toxic maintenance immunosuppressive regimen (e.g., lower-dose mycophenolate or azathioprine).
Answer
The correct sequence is: Obtain urinalysis/UPCR -> Perform renal biopsy -> Initiate induction therapy -> Transition to maintenance therapy.
The correct chronological management of suspected lupus nephritis begins with non-invasive biochemical confirmation via urinalysis and quantitative protein measurement. Because the histopathologic class of lupus nephritis dictates the necessity and intensity of immunosuppression, a renal biopsy is the mandatory next step prior to initiating aggressive systemic therapy. Once the class is established (e.g., diffuse proliferative lupus nephritis, Class IV), potent induction therapy is initiated to rapidly decrease inflammation. After remission is achieved—typically after 3 to 6 months—the patient is transitioned to a safer maintenance regimen to prevent relapses while avoiding the severe toxicities associated with prolonged induction therapy.
Step-by-Step Solution
Key Concept
The standard management of lupus nephritis requires non-invasive biochemical screening, followed by histologic classification via biopsy, leading to intensive induction therapy and eventual transition to maintenance therapy.